Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing.Superabsorbents are pads which are used to absorb and retain fluid in moderate to highly exudating wounds. GlobalData uses proprietary data and analytics to provide a comprehensive report on the superabsorbents devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the superabsorbents market in Japan was Molnlycke Health Care followed by Medline Industries, Smith & Nephew, Paul Hartmann, BSN Medical, Lohmann & Rauscher International, Hollister, 3M, ConvaTec Group and Coloplast.
The high absorption capacity reduces the risk of leakage and minimizes the risk of maceration around the wound. The Superabsorbent pad may be made of either foam, cellulose or hydropolymer. These dressings are majorly used for the treatment of chronic leg ulcers and chronic pressure ulcers where they provide a moist and active environment for optimum healing. This includes Antimicrobial Superabsorbents and Non-Antimicrobial Superabsorbents. Antimicrobial Superabsorbents are impregnated with an antimicrobial agent that inhibits microbial growth. Non-Antimicrobial Superabsorbents are devoid of antimicrobial activity due to absence of antimicrobial agents.
The value of the superabsorbents devices market within Japan was expected to be over $4m in 2023.
For the latest complete market share analysis of superabsorbents device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
